Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Henry R. Kravis currently holds 5,460,000 shares of JAZZ PHARMACEUTICALS INC (JAZZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Henry R. Kravis has been a net seller of JAZZ stock. They have purchased $21.9M and sold $6.4B worth of shares.
Henry R. Kravis's most recent insider trade was on Nov 12, 2025, when they sold 350,000 shares at $0.00 per share.
Henry R. Kravis serves as Executive at JAZZ PHARMACEUTICALS INC (JAZZ). They have executed 117 insider transactions totaling $6.4B over their tenure at the company.
Henry R. Kravis holds the position of Executive at JAZZ PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Henry R. Kravis has shown a selling trading pattern, with $21.9M in total purchases and $6.4B in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Henry R. Kravis was on Oct 22, 2025, when they sold $424.4M worth of BTSG shares. This transaction involved 14,745,000 shares at $28.78 per share.
Henry R. Kravis currently owns 5,460,000 shares of JAZZ PHARMACEUTICALS INC (JAZZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Henry R. Kravis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Henry R. Kravis has 117 Form 4 filings on record as an insider at JAZZ PHARMACEUTICALS INC.
Set alerts for Henry R. Kravis and 40,000+ other insiders.